Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

ExpreS2ion Biotechnologies – Rights Issue 2024

By Michael FriisHead of Equities
14.06.2024, 11.00
ExpreS2ion Biotech Holding

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

ExpreS2ion Biotechnologies is carrying out a rights issue with preferential rights for existing shareholders, amounting to approximately SEK 60 million. The company published its prospectus the 5 June 2024.

CEO Bent U. Frandsen and CFO Keith Alexander will join us on 14 June at 11.00 and take a deeper dive into details of the rights issue and warrant programs, timetable, rationale for the capital raise, and use of proceeds.

ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system.

Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 14.16, 7 June 2024.

Recent videos

DB
Danske Bank – Præsentation af regnskabet for 2. kvartal 2025
13.08.2025, 14.30 Danske Bank
Wi
Wirtek – Presentation of Q2 2025 Interim Report
13.08.2025, 13.30 Wirtek
NYAB
NYAB Q2´25: Strong Q2 sets tone for H2
13.08.2025, 12.53 NYAB
Ol
Olvi Oyj, Webcast, Q2'25
13.08.2025, 11.00 Olvi
CC
Copenhagen Capital – Præsentation af H1 og opdatering på strategiplaner
13.08.2025, 11.00 Copenhagen Capital
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.